Idiopathic Gastroparesis Drugs Market Insights, Global Outlook and Forecast 2022-2028
Idiopathic Gastroparesis Drugs Market Insights, Global Outlook and Forecast 2022-2028
Discover the latest insights into the booming Idiopathic Gastroparesis Drugs Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
The latest research study released by Market IntelliX evaluates market size and forecasts of Idiopathic Gastroparesis Drugs in Global, including the following market information:
Global Idiopathic Gastroparesis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Idiopathic Gastroparesis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prokinetic Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Idiopathic Gastroparesis Drugs include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm and Ani Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Idiopathic Gastroparesis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Idiopathic Gastroparesis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Idiopathic Gastroparesis Drugs Market Segment Percentages, by Type, 2021 (%)
Prokinetic Agents
Antiemetic Agents
Others
Global Idiopathic Gastroparesis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Idiopathic Gastroparesis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
Global Idiopathic Gastroparesis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Idiopathic Gastroparesis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Idiopathic Gastroparesis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Idiopathic Gastroparesis Drugs revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Idiopathic Gastroparesis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Idiopathic Gastroparesis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Idiopathic Gastroparesis Drugs Overall Market Size
2.1 Global Idiopathic Gastroparesis Drugs Market Size: 2021 VS 2028
2.2 Global Idiopathic Gastroparesis Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Idiopathic Gastroparesis Drugs Players in Global Market
3.2 Top Global Idiopathic Gastroparesis Drugs Companies Ranked by Revenue
3.3 Global Idiopathic Gastroparesis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Idiopathic Gastroparesis Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Idiopathic Gastroparesis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Idiopathic Gastroparesis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Idiopathic Gastroparesis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Idiopathic Gastroparesis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Idiopathic Gastroparesis Drugs Market Size Markets, 2021 & 2028
4.1.2 Prokinetic Agents
4.1.3 Antiemetic Agents
4.1.4 Others
4.2 By Type - Global Idiopathic Gastroparesis Drugs Revenue & Forecasts
4.2.1 By Type - Global Idiopathic Gastroparesis Drugs Revenue, 2017-2022
4.2.2 By Type - Global Idiopathic Gastroparesis Drugs Revenue, 2023-2028
4.2.3 By Type - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Idiopathic Gastroparesis Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Private Clinics
5.1.4 Drug Stores
5.1.5 E-Commerce
5.2 By Application - Global Idiopathic Gastroparesis Drugs Revenue & Forecasts
5.2.1 By Application - Global Idiopathic Gastroparesis Drugs Revenue, 2017-2022
5.2.2 By Application - Global Idiopathic Gastroparesis Drugs Revenue, 2023-2028
5.2.3 By Application - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Idiopathic Gastroparesis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Idiopathic Gastroparesis Drugs Revenue & Forecasts
6.2.1 By Region - Global Idiopathic Gastroparesis Drugs Revenue, 2017-2022
6.2.2 By Region - Global Idiopathic Gastroparesis Drugs Revenue, 2023-2028
6.2.3 By Region - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Idiopathic Gastroparesis Drugs Revenue, 2017-2028
6.3.2 US Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.3.3 Canada Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.3.4 Mexico Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Idiopathic Gastroparesis Drugs Revenue, 2017-2028
6.4.2 Germany Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.3 France Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.4 U.K. Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.5 Italy Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.6 Russia Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.4.8 Benelux Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Idiopathic Gastroparesis Drugs Revenue, 2017-2028
6.5.2 China Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.5.3 Japan Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.5.4 South Korea Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.5.6 India Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Idiopathic Gastroparesis Drugs Revenue, 2017-2028
6.6.2 Brazil Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.6.3 Argentina Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Idiopathic Gastroparesis Drugs Revenue, 2017-2028
6.7.2 Turkey Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.7.3 Israel Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Idiopathic Gastroparesis Drugs Market Size, 2017-2028
6.7.5 UAE Idiopathic Gastroparesis Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Sumitomo
7.1.1 Sumitomo Corporate Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Idiopathic Gastroparesis Drugs Major Product Offerings
7.1.4 Sumitomo Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.1.5 Sumitomo Key News
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Corporate Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Major Product Offerings
7.2.4 Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.2.5 Cadila Pharmaceuticals Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Idiopathic Gastroparesis Drugs Major Product Offerings
7.3.4 Sanofi Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Idiopathic Gastroparesis Drugs Major Product Offerings
7.4.4 Teva Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.4.5 Teva Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Idiopathic Gastroparesis Drugs Major Product Offerings
7.5.4 Johnson & Johnson Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Idiopathic Gastroparesis Drugs Major Product Offerings
7.6.4 Pfizer Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 Kyowa Kirin Pharmaceuticals
7.7.1 Kyowa Kirin Pharmaceuticals Corporate Summary
7.7.2 Kyowa Kirin Pharmaceuticals Business Overview
7.7.3 Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Major Product Offerings
7.7.4 Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.7.5 Kyowa Kirin Pharmaceuticals Key News
7.8 Hanmi Pharm
7.8.1 Hanmi Pharm Corporate Summary
7.8.2 Hanmi Pharm Business Overview
7.8.3 Hanmi Pharm Idiopathic Gastroparesis Drugs Major Product Offerings
7.8.4 Hanmi Pharm Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.8.5 Hanmi Pharm Key News
7.9 Ani Pharmaceuticals
7.9.1 Ani Pharmaceuticals Corporate Summary
7.9.2 Ani Pharmaceuticals Business Overview
7.9.3 Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Major Product Offerings
7.9.4 Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.9.5 Ani Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Idiopathic Gastroparesis Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|